ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0139

Preexisting Heart Failure Exacerbates Renal Medullary Tissue Hypoxia Following Cardiopulmonary Bypass in Sheep

Session Information

  • AKI: Mechanisms - 1
    November 06, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Trask-Marino, Anton Lewis, The Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia
  • Marino, Bruno, Cellsaving and Perfusion Resources, Melbourne, Victoria, Australia
  • Cochrane, Andrew Donald, Department of Cardiothoracic Surgery, Monash Health and Department of Surgery (School of Clinical Sciences at Monash Health), Monash University, Melbourne, Victoria, Australia
  • McCall, Peter Richmond, Austin Hospital Department of Anaesthesia, Heidelberg, Victoria, Australia
  • Raman, Jaishankar, Department of Cardiothoracic Surgery, St Vincent’s Hospital, The University of Melbourne, Melbourne, Victoria, Australia
  • Furukawa, Taku, The Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia
  • Ow, Connie, The Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia
  • Booth, Lindsea C., The Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia
  • May, Clive N., The Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia
  • Lankadeva, Yugeesh Ryan, The Florey Institute of Neuroscience and Mental Health, Melbourne, Victoria, Australia
Background

Acute kidney injury (AKI) is a major unresolved complication of cardiac surgery, particularly in patients with pre-existing heart failure (HF). Progress has been limited by a lack of clinically relevant animal models to study the complex pathophysiology. We developed a novel large animal model of HF with continuous assessment of renal tissue perfusion and oxygenation before, during and after cardiopulmonary bypass (CPB).

Methods

Merino ewes (30-45 kg) were instrumented to measure cardiac output (CO), mean arterial pressure (MAP), renal blood flow (RBF), renal oxygen delivery (RDO2), and renal cortical and medullary tissue perfusion and oxygenation (PO2) across pre- (conscious), intra- (anesthetized) and post-CPB (conscious) phases. HF was induced via coronary artery ligation and defined by ≥30% reduction in left ventricular ejection fraction. HF (n=9) and healthy control (n=8) animals underwent 2 h of CPB with aortic cross clamp (pump flow 2.4 L/min/m2, target MAP ~70 mmHg), followed by 48-h recovery.

Results

CPB reduced RBF and RDO2 similarly in both groups (RBF: -56% HF, -55% control; RDO2: -64% HF, -68% control; all p<0.01). Renal medullary tissue perfusion and PO2 also fell during CPB (perfusion: HF -71%, p=0.02; control -56%, p=0.08; PO2: HF -42%, p=0.03; control -46%, p=0.5), with no significant group differences. However, by 48-h post-CPB, medullary PO2 recovered in controls but remained markedly reduced in HF animals (8.0±3.7 vs 30.6±5.5 mmHg, p=0.02), despite similar MAP, CO, RBF, and renal cortical perfusion and PO2 between groups. HF animals had a numerically higher incidence of postoperative AKI (55% vs 12.5%, OR 8.75). Across both groups, sheep that developed AKI had significantly lower postoperative medullary PO2 than those without AKI (18.7±3.5 vs 31.3±3.5 mmHg, p=0.04).

Conclusion

In a clinically relevant large mammalian model of CPB, perioperative renal medullary hypoxia was associated with AKI. Pre-existing HF exacerbated this hypoxia during recovery, despite normalization of systemic hemodynamics and renal cortical oxygenation. Renal medullary hypoxia may represent a novel therapeutic target to prevent AKI following cardiac surgery, particularly in patients with pre-existing heart failure.

Digital Object Identifier (DOI)